TheCoveredCall.com Educates Investors on Trading Biotech Stocks


WEYMOUTH, Mass., Feb. 25, 2000 (PRIMEZONE) -- A wealthy old trader was once asked how he become so rich? The old trader replied that he always sold too early! The lesson of this story is that you have to know when to sell in order to realize a profit. Riding a stock up, only to watch it to eventually drop below your purchase price can be frustrating, especially for the novice investor.

TheCoveredCall.com, http://www.thecoveredcall.com shows investors how to leverage the covered call strategy in several biotech issues including Affymetrix (Nasdaq:AFFX), Amgen (Nasdaq:AMGN), Biogen (Nasdaq:BGEN), Human Genome Sciences (Nasdaq:HGSI).

"The covered call strategy is a great way to generate extra income for an investment portfolio. And if a stock's called away the investor's selling decision is made for them. The downside is the stock may go even higher than the strike price, but as we've seen in the blue chips and Internet stocks, what goes up, will eventually come down. Covered Calls provide a strategy that allows you to profit in these fast moving stocks, and potentially selling to early!" Stated Chris Baker.

TheCoveredCall.com, http://www.thecoveredcall.com is a leading Internet-based stock information service specializing in the C-A-N-S-L-I-M Strategy with a Covered Call twist which works great with 401k, IRAs and other cash/margin accounts.



            

Contact Data